Beginning March 12, 2015, NOVA Chemicals Corporation (the “Company”) will no longer make its financial statements available to the general public. However, (1) holders of notes of the Company, (2) bona fide prospective investors who are either qualified institutional buyers or are non-US persons, (3) securities analysts, or (4) market makers in Company notes, can access Company information through the Company’s password-protected online data system. If you are included in any one of the above categories and wish to view Company information, please contact Carolyn Rose per the contact information provided below. Prior to providing log-in details, Ms. Rose may require proof that you fall within one of the above categories and are entitled to access to the data site.

Carolyn Rose
Senior Corporate Paralegal

Selected Financial Information

Selected financial information, in millions of U.S. dollars, is provided below.






$    5,159

$      5,278

$       5,055

Operating profit – Olefins/Polyolefins

$    1,119

$      1,124

$          995

Operating profit – Styrenics

$            8

$             5

$              9


$        614

$         658

$          531

Cash provided by operating activities

$    1, 204

$         954

$       1,146

Capital expenditures

$        595

$         487

$          269

Total assets

$     6,328

$      6,205

$       5,609


$     3,345

$      3,521

$       2,859

2014 was one of our best years for PE sales at approximately 3.5 billion pounds, and was a record sales year for both PE2 and Moore LDPE – demonstrating our continued commitment to be leaders in our markets, aligning our efforts closely with our customers.

Full year 2014 operating profit for our Olefins/Polyolefins business unit remained strong and is consistent with full year 2013 operating profit.

During 2014, our capital expenditures were almost $600 million, an increase of more than 20% as compared to 2013, primarily due to continued spending on our NOVA 2020 growth projects. Capital spending in 2014 was slightly lower than the $700 million previously announced due to some PE 1 expansion costs shifting into 2015 and the lower Canadian dollar. Capital expenditures for 2015 are now expected to be around $850 million.


Pursuant to the Arrangement, a wholly-owned subsidiary of IPIC acquired all of NOVA Chemicals issued and outstanding common shares for US $6.00 per share on July 6, 2009.

Any questions and requests for assistance in surrendering certificates representing shares of NOVA Chemicals in order to receive consideration for such shares may be directed to the office of the depositary:

CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
320 Bay Street, Basement Level (B1)
Toronto, Ontario, M5H 4A6;
1-800-387-0825 (Canada/US) or 
                              (416) 682-3860 (outside Canada/US)

Non-registered shareholders should contact their broker or other intermediary for details.

If any holder of common shares fails to surrender to the depositary the certificates formerly representing common shares, together with such other documents required to entitle the holder to receive payment for his/her/its common shares, on or before July 6, 2015, such certificates will cease to represent a claim by or interest of any kind of a holder, and the payment to which the former holder was entitled will be deemed to have been surrendered and forfeited to IPIC for no consideration.

Contact Us:

Investor inquiries, please contact:
Tracey Simpson
Leader, External Financial Reporting

Media inquiries, please contact:
Pace Markowitz
Director, Communications